...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: OUCH!!! Things Move Faster In The Cancer Arena and Other Gems

Whatever....  they dropped .13cents, it could have jumped right back up .13 or more cents the next day ,  still no out of pocket expense in terms of shares that you had to pay for ,  

Share
New Message
Please login to post a reply